Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Nontuberculous Mycobacterium Infection: full-pipeline trial registry

2 of 2 indexed Nontuberculous Mycobacterium Infection trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Nontuberculous Mycobacterium Infection: 2 US clinical trials tracked, 2 recruiting.

Nontuberculous Mycobacterium Infection is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Chris Goss, running 1 of these trials.

Enrollment posture brief

Registry condition nontuberculous-mycobacterium-infection

OPEN 2 | RECR 100% | LATE 1 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Nontuberculous Mycobacte (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Nontuberculous Mycobacterium Infection

Nontuberculous Mycobacterium Infection lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Nontuberculous Mycobacterium Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Nontuberculous Mycobacterium Infection is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Nontuberculous Mycobacterium Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Gallium nitrate Drug
1 trials
Rifampin Drug
1 trials
Ethambutol Drug
1 trials
Hypertonic saline Drug
1 trials
Azithromycin Drug
1 trials

US sites by state

Facility locations filed on Nontuberculous Mycobacterium Infection trials. A trial with sites in several states counts in each.

Washington 1 trials
Vermont 1 trials
Texas 1 trials
South Carolina 1 trials
Pennsylvania 1 trials
Oregon 1 trials
Ohio 1 trials
New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Nontuberculous Mycobacterium Infection page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Nontuberculous Mycobacterium Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Chris Goss sponsors the most Nontuberculous Mycobacterium Infection trials on record, review their full trial history before evaluating a specific study. See Chris Goss's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Nontuberculous Mycobacterium Infection condition card totals 2 registered trials; most-linked intervention Gallium nitrate; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.